PRELUDE THERAPEUTICS INC Prepaid Expense and Other Assets, Noncurrent
PRELUDE THERAPEUTICS INC (PRLD) had Prepaid Expense and Other Assets, Noncurrent of $274.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent · last filed 2026-08-11
- 2026-06-30: Prepaid Expense and Other Assets, Noncurrent $274.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Noncurrent $314.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Noncurrent $110.00K.
- 2024-12-31: Prepaid Expense and Other Assets, Noncurrent $110.00K.
| Period end | Prepaid Expense and Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $274.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $314.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $110.00K 10-Q · filed 2026-08-11 |
| 2024-12-31 | $110.00K 10-K · filed 2026-03-10 |
| 2023-12-31 | $295.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $12.47M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $9.36M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $12.28M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $5.38M 10-K · filed 2024-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |